Insight

Patrick Hwu: Exited to talk with Anna Giuliano about the HPV Vaccine

Collage Photo of Patrick Hwu and Anna Giuliano

Aug 26, 2024, 06:26

Patrick Hwu: Exited to talk with Anna Giuliano about the HPV Vaccine

Patrick Hwu shared on LinkedIn:

“Excited to talk with colleague Anna Giuliano, founding director of the Center for Immunization and Infection Research in Cancer at Moffitt Cancer Center, about the HPV Vaccine.

Did you know it can prevent 6 cancer types?”

Patrick Hwu

Proceed to the video attached to the post.
Source: Patrick Hwu/LinkedIn

For more posts by Patrick Hwu, visit oncodaily.com

Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T cell therapy. He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.

Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years. Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research. Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.

Dr. Anna R. Giuliano is the founding Director of the Center for Immunization and Infection Research in Cancer at Moffitt Cancer Center. She has received two awards from the American Cancer Society. Her 28-year career began with research on HPV and cervical cancer in women and now includes studies on HPV-related cancers in men and other cancer-related infectious diseases.